CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer [Phase 3]
Summary
Phase 3 trial comparing vinflunine to an alkylating agent in metastatic breast cancer completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pierre Fabre Medicament | Conditions: Breast Cancer, Metastases | Phase 3 | Status: COMPLETED | Results posted: 2019-09-16